Seattle Genetics Presents Final Lintuzumab Phase I Clinical Data

News   Jun 10, 2009

 
Seattle Genetics Presents Final Lintuzumab Phase I Clinical Data
 
 
 

RELATED ARTICLES

Extra-Resistant Wheat is Created From New Gene Combination

News

A new combination of different strains of resistant wheat may help farmers avoid a common fungal disease.

READ MORE

Anti-Inflammatory Pill Could Make Vaccines More Effective for the Elderly

News

By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

READ MORE

Adaptive PCR Technique Offers Simpler Alternative

News

Researchers claim their new technique can use L-DNA to sidestep many of the issues that make current PCR techniques frustrating.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE